Skip to content

Antihistamine for Prevention of HTR After Blood Primed CPB

Prophylactic Antihistamine for Prevention of Hypotensive Transfusion Reaction After Blood Primed Cardiopulmonary Bypass in Pediatric Cardiac Surgery: a Randomized-controlled Study

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07536152
Acronym
HTR - CPB
Enrollment
40
Registered
2026-04-17
Start date
2026-03-01
Completion date
2026-12-01
Last updated
2026-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood Transfusion Associated Adverse Reactions

Keywords

prevention of hypotensive transfusion reaction

Brief summary

This study will be a randomized, double-blinded, placebo-controlled study conducted at a university hospital. Forty children undergoing elective repair of a congenital heart defect will be included. The patients will be randomly allocated (20 patients per group) to receive a single intravenous dose of combined chlorpheniramine or normal saline immediately after separation from CPB, before protamine administration.

Interventions

DRUGAntihestamine

chlorpheniramine 0.25 mg/Kg in 2 ml immediately after separation from CPB, before protamine administration

DRUGPlacebo

equal volume normal saline

Sponsors

Kasr El Aini Hospital
Lead SponsorOTHER
Misr University for Science and Technology
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
1 Years to 7 Years
Healthy volunteers
No

Inclusion criteria

* Acyanotic congenital heart disease. * Age :1 -7 years. * Genre: both.

Exclusion criteria

* Redo patient. * History of allergy to antihistamines. * Bleeding disorders with INR \> 1.5 and/or platelets \< 50,000. * Emergency procedure.

Design outcomes

Primary

MeasureTime frameDescription
hypotention episode incidance15 min,post cardiopulmonary bypass weaningIncidence of hypotension (20% MBP drop \< baseline)15 minutes post-CBP weaning

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 22, 2026